Suppression of ghrelin exacerbates HFCS-induced adiposity and insulin resistance

International Journal of Molecular Sciences

Volumn 18, Issue 6, 2017, Pages

  Ma, Xiaojun ^a,b   Lin, Ligen ^b,c   Yue, Jing ^b,d   Wu, Chia Shan ^e   Guo, Cathy A ^e   Wang, Ruitao ^f   Yu, Kai Jiang ^f   Devaraj, Sridevi ^b   Murano, Peter ^e   Chen, Zheng ^g   Sun, Yuxiang ^b,e  

^a ZHENGZHOU UNIVERSITY   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MACAU   (Macao)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e TEXAS A AND M UNIVERSITY   (United States)

^f HARBIN MEDICAL UNIVERSITY   (China)

^g UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Adipose tissue inflammation; Adiposity; Fructose; Ghrelin; Glucose; HFCS; Insulin resistance; Sucrose

Indexed keywords

CORN SYRUP; FRUCTOSE; GHRELIN; GLUCOSE; INSULIN; SUCROSE; SWEETENING AGENT;

ABLATION THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALORIC INTAKE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE EXACERBATION; ENERGY CONSUMPTION; ENERGY EXPENDITURE; EXPERIMENTAL OBESITY; FLOW CYTOMETRY; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INDIRECT CALORIMETRY; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; LEAN BODY WEIGHT; LOCOMOTION; LUNG GAS EXCHANGE; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; RESTING METABOLIC RATE; WEIGHT GAIN; ADIPOSE TISSUE; ANALYSIS; ANIMAL; BLOOD; BODY COMPOSITION; BODY WEIGHT; C57BL MOUSE; DIET; DRUG EFFECTS; ENERGY METABOLISM; ETHNOLOGY; GENETICS; KNOCKOUT MOUSE; METABOLISM; OBESITY; PHYSIOLOGY;

ADIPOSE TISSUE; ADIPOSITY; ANIMALS; BLOOD GLUCOSE; BODY COMPOSITION; BODY WEIGHT; DIET; ENERGY METABOLISM; GHRELIN; GLUCOSE TOLERANCE TEST; HIGH FRUCTOSE CORN SYRUP; INFLAMMATION; INSULIN; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; SUCROSE; SWEETENING AGENTS;

EID: 85021098777     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18061302     Document Type: Article

References (49)

1. Narayan, K.M., Boyle, J.P., Thompson, T.J., Gregg, E.W., Williamson, D.F. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care 2007, 30, 1562-1566.
2. Obesity and Overweight. Available online: http://www.webcitation.org/6lMlR2JKb (accessed on 19 October 2016).
3. Stanhope, K.L., Schwarz, J.M., Keim, N.L., Griffen, S.C., Bremer, A.A., Graham, J.L., Hatcher, B., Cox, C.L., Dyachenko, A., Zhang, W., et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Investig. 2009, 119, 1322-1334.
4. Sugar: World Markets and Trade. Available online: http://www.webcitation.org/6lMlzulSK (accessed on 19 October 2016).
5. U.S. Sugar Production. Available online: http://www.webcitation.org/6lMxFogOE (accessed on 19 October 2016).
6. Bray, G.A., Nielsen, S.J., Popkin, B.M. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am. J. Clin. Nutr. 2004, 79, 537-543.
7. Lustig, R.H. Childhood obesity: Behavioral aberration or biochemical drive? Reinterpreting the First Law of Thermodynamics. Nat. Clin. Pract. Endocrinol. Metab. 2006, 2, 447-458.
8. Mietus-Snyder, M.L., Lustig, R.H. Childhood obesity: Adrift in the “limbic triangle”. Annu. Rev. Med. 2008, 59, 147-162.
9. Stanhope, K.L., Havel, P.J. Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose, or high-fructose corn syrup. Am. J. Clin. Nutr. 2008, 88, 1733S-1737S.
10. Melanson, K.J., Angelopoulos, T.J., Nguyen, V., Zukley, L., Lowndes, J., Rippe, J.M. High-fructose corn syrup, energy intake, and appetite regulation. Am. J. Clin. Nutr. 2008, 88, 1738S-1744S.
11. Melanson, K.J., Zukley, L., Lowndes, J., Nguyen, V., Angelopoulos, T.J., Rippe, J.M. Effects of high-fructose corn syrup and sucrose consumption on circulating glucose, insulin, leptin, and ghrelin and on appetite in normal-weight women. Nutrition 2007, 23, 103-112.
12. Kojima, M., Kangawa, K. Ghrelin: Structure and function. Physiol. Rev. 2005, 85, 495-522.
13. Sun, Y., Wang, P., Zheng, H., Smith, R.G. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc. Natl. Acad. Sci. USA 2004, 101, 4679-4684.
14. Andrews, Z.B., Liu, Z.W., Walllingford, N., Erion, D.M., Borok, E., Friedman, J.M., Tschop, M.H., Shanabrough, M., Cline, G., Shulman, G.I., et al. UCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicals. Nature 2008, 454, 846-851.
15. Perez-Tilve, D., Heppner, K., Kirchner, H., Lockie, S.H., Woods, S.C., Smiley, D.L., Tschop, M., Pfluger, P. Ghrelin-induced adiposity is independent of orexigenic effects. FASEB J. 2011, 25, 2814-2822.
16. Sun, Y., Asnicar, M., Saha, P.K., Chan, L., Smith, R.G. Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab. 2006, 3, 379-386.
17. Lin, L., Saha, P.K., Ma, X., Henshaw, I.O., Shao, L., Chang, B.H., Buras, E.D., Tong, Q., Chan, L., McGuinness, O.P., et al. Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissues. Aging Cell 2011, 10, 996-1010.
18. Davies, J.S., Kotokorpi, P., Eccles, S.R., Barnes, S.K., Tokarczuk, P.F., Allen, S.K., Whitworth, H.S., Guschina, I.A., Evans, B.A., Mode, A., et al. Ghrelin induces abdominal obesity via GHS-R-dependent lipid retention. Mol. Endocrinol. 2009, 23, 914-924.
19. Delhanty, P.J., van der Eerden, B.C., van der Velde, M., Gauna, C., Pols, H.A., Jahr, H., Chiba, H., van der Lely, A.J., van Leeuwen, J.P. Ghrelin and unacylated ghrelin stimulate human osteoblast growth via mitogen-activated protein kinase (MAPK)/phosphoinositide 3-kinase (PI3K) pathways in the absence of GHS-R1a. J. Endocrinol. 2006, 188, 37-47.
20. Gauna, C., Delhanty, P.J., Hofland, L.J., Janssen, J.A., Broglio, F., Ross, R.J., Ghigo, E., van der Lely, A.J. Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes. J. Clin. Endocrinol. Metab. 2005, 90, 1055-1060.
21. Teff, K.L., Elliott, S.S., Tschop, M., Kieffer, T.J., Rader, D., Heiman, M., Townsend, R.R., Keim, N.L., D’Alessio, D., Havel, P.J., et al. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J. Clin. Endocrinol. Metab. 2004, 89, 2963-2972.
22. Foster-Schubert, K.E., Overduin, J., Prudom, C.E., Liu, J., Callahan, H.S., Gaylinn, B.D., Thorner, M.O., Cummings, D.E. Acyl and total ghrelin are suppressed strongly by ingested proteins, weakly by lipids, and biphasically by carbohydrates. J. Clin. Endocrinol. Metab. 2008, 93, 1971-1979.
23. Bocarsly, M.E., Powell, E.S., Avena, N.M., Hoebel, B.G. High-fructose corn syrup causes characteristics of obesity in rats: Increased body weight, body fat and triglyceride levels. Pharmacol. Biochem. Behav. 2010, 97, 101-106.
24. Ma, X., Lin, L., Yue, J., Pradhan, G., Qin, G., Minze, L.J., Wu, H., Sheikh-Hamad, D., Smith, C.W., Sun, Y., et al. Ghrelin receptor regulates HFCS-induced adipose inflammation and insulin resistance. Nutr. Diabetes 2013, 3, e99.
25. Lumeng, C.N., Bodzin, J.L., Saltiel, A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Investig. 2007, 117, 175-184.
26. Brake, D.K., Smith, E.O., Mersmann, H., Smith, C.W., Robker, R.L. ICAM-1 expression in adipose tissue: Effects of diet-induced obesity in mice. Am. J. Physiol. Cell Physiol. 2006, 291, C1232-C1239.
27. Wu, H., Ghosh, S., Perrard, X.D., Feng, L., Garcia, G.E., Perrard, J.L., Sweeney, J.F., Peterson, L.E., Chan, L., Smith, C.W., et al. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 2007, 115, 1029-1038.
28. Dietrich, M.O., Antunes, C., Geliang, G., Liu, Z.W., Borok, E., Nie, Y., Xu, A.W., Souza, D.O., Gao, Q., Diano, S., et al. Agrp neurons mediate Sirt1’s action on the melanocortin system and energy balance: Roles for Sirt1 in neuronal firing and synaptic plasticity. J. Neurosci. 2010, 30, 11815-11825.
29. Dixit, V.D., Schaffer, E.M., Pyle, R.S., Collins, G.D., Sakthivel, S.K., Palaniappan, R., Lillard, J.W., Jr., Taub, D.D. Ghrelin inhibits leptin-and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J. Clin. Investig. 2004, 114, 57-66.
30. Li, W.G., Gavrila, D., Liu, X., Wang, L., Gunnlaugsson, S., Stoll, L.L., McCormick, M.L., Sigmund, C.D., Tang, C., Weintraub, N.L. Ghrelin inhibits proinflammatory responses and nuclear factor-_B activation in human endothelial cells. Circulation 2004, 109, 2221-2226.
31. Waseem, T., Duxbury, M., Ito, H., Ashley, S.W., Robinson, M.K. Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways. Surgery 2008, 143, 334-342.
32. Schaefer, E.J., Gleason, J.A., Dansinger, M.L. Dietary fructose and glucose differentially affect lipid and glucose homeostasis. J. Nutr. 2009, 139, 1257S-1262S.
33. Curry, D.L. Effects of mannose and fructose on the synthesis and secretion of insulin. Pancreas 1989, 4, 2-9.
34. Montgomery, M.K., Fiveash, C.E., Braude, J.P., Osborne, B., Brown, S.H., Mitchell, T.W., Turner, N. Disparate metabolic response to fructose feeding between different mouse strains. Sci. Rep. 2015, 5, 18474.
35. Dixit, V.D., Yang, H., Sun, Y., Weeraratna, A.T., Youm, Y.H., Smith, R.G., Taub, D.D. Ghrelin promotes thymopoiesis during aging. J. Clin. Investig. 2007, 117, 2778-2790.
36. Hattori, N., Saito, T., Yagyu, T., Jiang, B.H., Kitagawa, K., Inagaki, C. GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J. Clin. Endocrinol. Metab. 2001, 86, 4284-4291.
37. Poykko, S.M., Kellokoski, E., Horkko, S., Kauma, H., Kesaniemi, Y.A., Ukkola, O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003, 52, 2546-2553.
38. Amini, P., Wadden, D., Cahill, F., Randell, E., Vasdev, S., Chen, X., Gulliver, W., Zhang, W., Zhang, H., Yi, Y., et al. Serum acylated ghrelin is negatively correlated with the insulin resistance in the coding study. PLoS ONE 2012, 7, e45657.
39. Ma, X., Lin, L., Qin, G., Lu, X., Fiorotto, M., Dixit, V.D., Sun, Y. Ablations of ghrelin and ghrelin receptor exhibit differential metabolic phenotypes and thermogenic capacity during aging. PLoS ONE 2011, 6, e16391.
40. Szentirmai, E., Kapas, L., Sun, Y., Smith, R.G., Krueger, J.M. The preproghrelin gene is required for the normal integration of thermoregulation and sleep in mice. Proc. Natl. Acad. Sci. USA 2009, 106, 14069-14074.
41. Zhang, J.V., Ren, P.G., Avsian-Kretchmer, O., Luo, C.W., Rauch, R., Klein, C., Hsueh, A.J. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake. Science 2005, 310, 996-999.
42. Delhanty, P.J., Sun, Y., Visser, J.A., van Kerkwijk, A., Huisman, M., van Ijcken, W.F., Swagemakers, S., Smith, R.G., Themmen, A.P., van der Lely, A.J., et al. Unacylated ghrelin rapidly modulates lipogenic and insulin signaling pathway gene expression in metabolically active tissues of GHSR deleted mice. PLoS ONE 2010, 5, e11749.
43. Tang-Christensen, M., Vrang, N., Ortmann, S., Bidlingmaier, M., Horvath, T.L., Tschop, M. Central administration of ghrelin and agouti-related protein (83-132) increases food intake and decreases spontaneous locomotor activity in rats. Endocrinology 2004, 145, 4645-4652.
44. Granado, M., Martin, A.I., Lopez-Menduina, M., Lopez-Calderon, A., Villanua, M.A. Gh-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia. Am. J. Physiol. Endocrinol. Metab. 2008, 294, E131-E141.
45. Fujisaka, S., Usui, I., Bukhari, A., Ikutani, M., Oya, T., Kanatani, Y., Tsuneyama, K., Nagai, Y., Takatsu, K., Urakaze, M., et al. Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 2009, 58, 2574-2582.
46. Sun, Y., Ahmed, S., Smith, R.G. Deletion of ghrelin impairs neither growth nor appetite. Mol. Cell. Biol. 2003, 23, 7973-7981.
47. Lee, J.H., Lin, L., Xu, P., Saito, K., Wei, Q., Meadows, A.G., Bongmba, O.Y., Pradhan, G., Zheng, H., Xu, Y., et al. Neuronal deletion of ghrelin receptor almost completely prevents diet-induced obesity. Diabetes 2016, 65, 2169-2178.
48. He, B., Nohara, K., Park, N., Park, Y.S., Guillory, B., Zhao, Z., Garcia, J.M., Koike, N., Lee, C.C., Takahashi, J.S., et al. The small molecule nobiletin targets the molecular oscillator to enhance circadian rhythms and protect against metabolic syndrome. Cell Metab. 2016, 23, 610-621.
49. Mathis, D., Shoelson, S.E. Immunometabolism: An emerging frontier. Nat. Rev. Immunol. 2011, 11, 81-83.